Characterization of CD19+CD23+ B2 lymphocytes in the allergic airways of BALB/c mice in response to the inhalation of Aspergillus fumigatus conidia

Open Immunology Journal

Volumn 5, Issue 1, 2012, Pages 46-54

  Ghosh, Sumit ^a   Hoselton, Scott A ^a   Schuh, Jane M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Ab production; B lymphocytes; Fungal asthma; Murine model

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ASPERGILLUS FUMIGATUS; B LYMPHOCYTE ACTIVATION; CONIDIUM; CONTROLLED STUDY; CYTOKINE RESPONSE; ENVIRONMENTAL EXPOSURE; FLOW CYTOMETRY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 84881354177     PISSN: None     EISSN: 18742262     Source Type: Journal    
DOI: 10.2174/1874226201205010046     Document Type: Article

References (42)

1. Dagenais TR, Keller NP. Pathogenesis of aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009; 22: 447-65.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
3. Beck O, Topp MS, Koehl U, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006; 107: 2562-9.
4. Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect Dis 1997; 176: 1579-83.
5. Traynor TR, Huffnagle GB. Role of chemokines in fungal infections. Med Mycol 2001; 39: 41-50.
6. Murdock BJ, Shreiner AB, McDonald RA, et al. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun 2011; 79: 125-35.
7. Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005; 127: 1252-9.
8. Schwartz HJ, Citron KM, Chester EH, et al. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 1978; 62: 9-14.
9. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-26.
10. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
11. Lorenz RG, McCracken VJ, Elson CO. Animal models of intestinal inflammation: ineffective communication between coalition members. Springer Semin Immunopathol 2005; 27: 233-47.
12. Samarasinghe AE, Hoselton SA, Schuh JM. The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice. Peptides 2011; 32: 131-7.
13. Yuan R, Clynes R, Oh J, Ravetch JV, Scharff MD. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 1998; 187: 641-8.
14. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175: 5439-47.
15. el-Dahr JM, Fink R, Selden R, Arruda LK, Platts-Mills TA, Heymann PW. Development of immune responses to Aspergillus at an early age in children with cystic fibrosis. Am J Respir Crit Care Med 1994; 150(6 Pt 1): 1513-8.
16. Krasnick J, Greenberger PA, Roberts M, Patterson R. Allergic bronchopulmonary aspergillosis: serologic update for 1995. J Clin Lab Immunol 1995; 46: 137-42.
17. Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005; 1(3): e30.
18. Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, Garvy BA. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 2006; 176: 6147-54.
19. Hoselton SA, Samarasinghe AE, Seydel JM, Schuh JM. An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice. Med Mycol 2010; 48: 1056-65.
20. Samarasinghe AE, Hoselton SA, Schuh JM. A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice. Fungal Biol 2011; 115: 21-9.
21. Oliveira FL, Aguiar AM, Borojevic R, El-Cheikh MC. IgE expression on the surface of B1 and B2 lymphocytes in experimental murine schistosomiasis. Braz J Med Biol Res 2005; 38: 1033-42.
22. Wang H, Clarke SH. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J Immunol 2003; 171: 6381-8.
23. Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001; 13: 195-201.
24. Ibrahim-Granet O, Philippe B, Boleti H, et al. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 2003; 71: 891-903.
25. Cenci E, Mencacci A, Fe Dd'Ostiani C, et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750-60.
26. Polonelli L, Casadevall A, Han Y, et al. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol 2000; 38(Suppl 1): 281-92.
27. Yoshizawa Y, Ohtani Y, Inoue T, et al. Immune responsiveness to inhaled antigens: local antibody production in the respiratory tract in health and lung diseases. Clin Exp Immunol 1995; 100: 395-400.
28. Walker CA, Fitzharris P, Longbottom JL, Taylor AJ. Lymphocyte sensitization to Aspergillus fumigatus in allergic bronchopulmo-nary aspergillosis. Clin Exp Immunol 1989; 76: 34-40.
29. Ghosh S, Hoselton SA, Schuh JM. Mu-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J Immunol 2012; 189: 1322-9.
30. Lindell DM, Berlin AA, Schaller MA, Lukacs NW. B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS One 2008; 3: 3129.
31. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008; 1: 11-22.
32. Blanco JL, Garcia ME. Immune response to fungal infections. Vet Immunol Immunopathol 2008; 125: 47-70.
33. Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009; 47 (Suppl 1): S331-7.
34. Mukherjee S, Lee SC, Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995; 63: 573-9.
35. Snow RE, Djukanovic R, Stevenson FK. Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 1999; 98: 646-51.
36. Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, Hogaboam CM. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 2001; 166: 5219-24.
37. Grunig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-3.
38. Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002; 8: 885-9.
39. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111: 450-463; quiz 64.
40. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997; 185: 885-92.
41. Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol 1999; 21: 480-9.
42. Oshiba A, Hamelmann E, Takeda K, et al. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 1996; 97: 1398-408.